What is Orthocell’s main product?

Remplir, a medical device for nerve repair surgeries.

Which markets currently use Remplir?

Australia, Singapore, and the United States.

ASX 200 Orthocell expands Remplir rollout in United States nerve repair sector

3 min read | August 13, 2025 04:43 PM AEST | By Team Kalkine Media

Google News:

ASX 200 Orthocell expands Remplir rollout in United States nerve repair sector — Image source: Shutterstock

Early adoption in the United States

Multiple surgical procedures have now been completed in the United States using Remplir. This initial phase is aimed at building familiarity among surgeons, similar to successful launches in markets such as Australia and Singapore. These early-stage procedures serve as a foundation for broader clinical uptake and further integration into hospital networks.

Progress with Value Assessment Committees

Orthocell is working closely with its distribution network to secure approvals from hospital Value Assessment Committees. These committees assess clinical efficacy, safety, and procedural benefits before granting access to use new medical devices within their facilities. Applications are being supported by surgeons affiliated with the targeted hospitals, helping to align procedural adoption with local clinical capabilities.

Distribution and logistics readiness

To facilitate procedural demand, Orthocell has shipped Remplir units to its United States logistics partner, Uniphar. This partnership ensures timely delivery and availability of the product for hospitals and surgeons conducting nerve repair surgeries. All units supplied to the US market are manufactured at Orthocell’s facility in Western Australia, maintaining consistent quality standards.

Strengthening of US-based operations

The company has enhanced its on-ground presence in the United States by adding experienced personnel to its team, including a regional sales director with specific expertise in the nerve repair space. This move is intended to support engagement with healthcare providers, streamline procedural training, and coordinate with distributors on expanding market reach.

Momentum in the commercialisation strategy

The commercialisation approach in the United States is being executed in stages, beginning with targeted hospitals and gradually broadening to additional healthcare facilities. With a growing base of trained surgeons and ongoing procedural adoption, Orthocell is reinforcing its footprint in the competitive nerve repair market.

Frequently Asked Questions

What is Orthocell’s main product?
Remplir, a medical device for nerve repair surgeries.
Where is Remplir manufactured?
At Orthocell’s facility in Western Australia.
Which markets currently use Remplir?
Australia, Singapore, and the United States.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.